quote:
The part where the Federal Government-under the Trump Administration-completely shut down treatment studies. They didn’t want to treat COVID. They just wanted a cure.

A possible reason for that is described here.

The above link is to the FDA’s webpage where they describe emergency use authorizations. The 3rd paragraph includes this quote:

quote:
Under an EUA, FDA may allow the use of unapproved medical products, or unapproved uses of approved medical products in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when certain statutory criteria have been met, including that there are no adequate, approved, and available alternatives.

Stated another way, it is a legal requirement for emergency use authorizations that no adequate, approved AND available treatment alternative exists. So for a mass vaccination treatment strategy to exist (which coincidentally is also a highly controlled profit making opportunity because it focuses expenditures to fewer investment vehicles), no other alternative can be allowed until the decision makers say so.

0 ...

Report Post

Posted by winkchance

St. George, LA

Member since Jul 2016

4106 posts

Posted on 12/29/21 at 7:49 am to Bourre

quote:

Hospitals didn’t/don’t want to treat, it’s plain and simple.

This is it - medicine today is about tests and not treating symptoms.

0 ...

Report Post

Posted by Willie Stroker

Member since Sep 2008

12877 posts

Posted on 12/29/21 at 8:50 am to TigerFanatic99

quote:
quote: his treatment steps What does he propose?

Here is the full text of the article he published and co-authored in the American Journal of Medicine back in August of 2020.

Another article was recently updated a few weeks ago and can be viewed here.

The most relevant points are:

quote:
The vitamin and supplement protocol includes: quercetin, zinc sulfate, Vitamin D3, and Vitamin C. McCullough said he doesn’t have any evidence to believe these help prevent contracting the illness, but he believes they should be included in the early treatment protocol as supportive therapies.

Because the virus replicates rapidly, McCullough recommends using a course of 200 milligrams (mg) of hydroxychloroquine twice a day for at least five days. Of all the therapies he used, McCullough believed this helped him the most during his illness.

“Hydroxychloroquine far and away made the biggest difference,” McCullough commented. “It is not a cure alone, but it makes a giant difference.”

If a patient has known heart issues that put them at risk when taking hydroxychloroquine, McCullough offers ivermectin as an alternative.

He also believes the United States needs to immediately investigate the efficacy of favipiravir, which he says is being used successfully as a treatment in 30 countries around the world.

Along with hydroxychloroquine, McCullough’s protocol suggests a course of antibiotics, such as doxycycline or azithromycin, to help reduce the chance of secondary infections.

The risk of blood clotting is one of the most frightening aspects of the disease, McCullough acknowledged, and thus he has updated his earlier advice to increase the recommended dosage of aspirin to 325 mg daily.